Market revenue in 2023 | USD 200.3 million |
Market revenue in 2030 | USD 682.1 million |
Growth rate | 19.1% (CAGR from 2023 to 2030) |
Largest segment | Synthetic |
Fastest growing segment | Biotech |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Synthetic, Biotech |
Key market players worldwide | Basf SE, CordenPharma, Bristol-Myers Squibb Co, Pfizer Inc, Boehringer Ingelheim Pharma, Dr. Reddy’s Laboratories, Sun Pharmaceutical Industries, Albany Molecular Research, Sanofi SA, Lonza Group Ltd, Cipla Ltd DR, Merck & Co Inc, Teva Pharmaceutical Industries Ltd, Novartis AG ADR, Roche Holding AG |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to high potency active pharmaceutical ingredients market will help companies and investors design strategic landscapes.
Synthetic was the largest segment with a revenue share of 72.09% in 2023. Horizon Databook has segmented the Russia high potency active pharmaceutical ingredients market based on synthetic, biotech covering the revenue growth of each sub-segment from 2018 to 2030.
In 2012, government-backed investment venture, funded emerging investment firms in Russia to modernize healthcare in the country. Furthermore, government collaborations, such as US-Russia bilateral collaboration in 2016 to stimulate and facilitate cancer research, are also anticipated to impact the market positively.
In Russia, around 14.65% population is aged over 65 and is categorized as geriatric, which is more susceptible to cancer and diabetes. In Russia, over 314,611 patients die annually due to cancer, which indicates a strong need for efficient oncology therapeutics in the country. This unmet need for high efficacy therapeutics is anticipated to drive the market growth over the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the Russia high potency active pharmaceutical ingredients market , including forecasts for subscribers. This country databook contains high-level insights into Russia high potency active pharmaceutical ingredients market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account